In Vitro Diagnostics (IVD) Quality Controls: Global Market

Report Highlights

The global in vitro diagnostic (IVD) quality controls market should reach $1.6 billion by 2027 from $1.2 billion in 2022 at a compound annual growth rate (CAGR) of 5.5% for the forecast period of 2022 to 2027.

Report Includes

• 26 data tables and 24 additional tables
• An overview of the global market for in vitro diagnostics (IVD) quality controls market
• Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022 with projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the market potential for in vitro diagnostics (IVD) quality controls market, based on test type, manufacturer, products and services, end user, and region
• Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
• Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
• Company profiles of major players, including Abbott Laboratories, Bio-Rad Laboratories Inc., LGC Ltd., Siemens Healthineers AG, and ThermoFisher Scientific Inc.

Report Scope

The current report provides detailed information regarding the in vitro diagnostics quality controls market. This report highlights the current and future market potential of in vitro diagnostics controls and a detailed analysis of the drivers and challenges in the market. The report also covers market projections to 2027 and market rank for key market players. It also covers the competitive environment and regulatory scenario. The report details the market share of IVD controls based on test type, products and services, manufacturer, application and end user.

Based on test type, the market is segmented into immunoassays, clinical chemistry, hematology and hemostasis, molecular diagnostics, microbiology and others. Based on products and services, controls are categorized into quality control products, data management solutions, and quality assurance services. Based on manufacturer, the market is segmented into third-party controls and OEM controls. Based on end users, the market is segmented into hospitals, diagnostic laboratories and academic institutions.

The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. The report also includes impact of the COVID-19 pandemic on this market.

By geography, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of the world. The North America region includes the U.S., Canada and Mexico. Europe includes Germany, U.K., Italy and Rest of Europe. Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific.

For market estimates, data has been provided for the 2020 as the historic year, 2021 as the base year and forecast for 2027.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
• Carbon Credits Market: Global Outlook (EGY200A)
• Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
• Global Flame and Smoke Detectors Markets (MFG092A)
• Biodegradable Polymers: Global Markets and Technologies (PLS025K)